Want to see HK:2898 full AI Analyst Report?
Sunho Biologics,Inc. (2898) Ratios
Sunho Biologics,Inc. Ratios
HK:2898's free cash flow for Q2 2025 was $-41.23M. For the 2025 fiscal year, HK:2898's free cash flow was decreased by $-7.31M and operating cash flow was $-33.92M. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 11.17 | 0.59 | 0.22 | 0.37 |
| Quick Ratio | 11.15 | 0.58 | 0.21 | 0.35 |
| Cash Ratio | 1.79 | 0.32 | 0.03 | 0.18 |
| Solvency Ratio | -1.51 | -0.31 | -0.60 | -0.32 |
| Operating Cash Flow Ratio | -2.47 | -0.10 | -0.52 | -0.91 |
| Short-Term Operating Cash Flow Coverage | -3.18 | 0.00 | -7.18 | 0.00 |
| Net Current Asset Value | $ 444.20M | $ -167.42M | $ -57.73M | $ -195.11M |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.07 | 0.03 | 0.16 | 1.89 |
| Debt-to-Equity Ratio | 0.08 | -0.09 | -7.35 | -1.22 |
| Debt-to-Capital Ratio | 0.07 | -0.10 | 1.16 | 5.49 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 1.32 | 5.90 |
| Financial Leverage Ratio | 1.10 | -2.79 | -47.27 | -0.65 |
| Debt Service Coverage Ratio | -2.77 | -178.28 | -3.85 | 0.00 |
| Interest Coverage Ratio | 0.00 | -95.68 | -11.21 | 0.00 |
| Debt to Market Cap | 0.08 | 0.00 | 0.01 | 0.15 |
| Interest Debt Per Share | 0.32 | 0.11 | 0.18 | 1.77 |
| Net Debt to EBITDA | 0.40 | 0.94 | -0.24 | -2.34 |
| Profitability Margins | ||||
| Gross Profit Margin | 100.00% | 0.79% | 27.33% | 100.00% |
| EBIT Margin | -266723.68% | -752.87% | -2710.23% | -2071.39% |
| EBITDA Margin | -249876.32% | -703.60% | -2201.39% | -1996.70% |
| Operating Profit Margin | -266723.68% | -377.60% | -3285.90% | -2071.39% |
| Pretax Profit Margin | -210434.21% | -756.82% | -3003.35% | -2196.27% |
| Net Profit Margin | -210434.21% | -756.82% | -3003.35% | -2196.27% |
| Continuous Operations Profit Margin | -210434.21% | -756.82% | -3003.35% | -2196.27% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 78.90% | 200.43% | 91.40% | 106.03% |
| Return on Assets (ROA) | -14.26% | -45.69% | -73.37% | -83.14% |
| Return on Equity (ROE) | -15.62% | 127.46% | 3468.18% | 53.69% |
| Return on Capital Employed (ROCE) | -19.62% | 68.11% | -1208.39% | -248.02% |
| Return on Invested Capital (ROIC) | -18.32% | 69.67% | -597.09% | -227.29% |
| Return on Tangible Assets | -14.52% | -47.32% | -85.42% | -94.23% |
| Earnings Yield | -17.56% | -10.86% | -4.45% | -6.56% |
| Efficiency Ratios | ||||
| Receivables Turnover | 0.00 | 13.61 | 0.52 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.09 | 1.43 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.35 | 0.04 | 0.06 |
| Asset Turnover | 0.00 | 0.06 | 0.02 | 0.04 |
| Working Capital Turnover Ratio | 0.00 | -0.17 | -0.04 | 0.00 |
| Cash Conversion Cycle | 0.00 | 4292.10 | 955.67 | 0.00 |
| Days of Sales Outstanding | 0.00 | 26.81 | 700.06 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 4265.29 | 255.62 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 4292.10 | 955.67 | 0.00 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -0.85 | -0.44 | -0.38 | -0.58 |
| Free Cash Flow Per Share | -1.23 | -0.45 | -0.39 | -0.64 |
| Dividend Paid and CapEx Coverage Ratio | -2.21 | -39.47 | -24.03 | -9.55 |
| Capital Expenditure Coverage Ratio | -2.21 | -39.47 | -24.03 | -9.55 |
| Operating Cash Flow Coverage Ratio | -2.65 | -4.48 | -3.14 | -0.33 |
| Operating Cash Flow to Sales Ratio | -2868.95 | -2.32 | -19.98 | -16.37 |
| Free Cash Flow Yield | -34.75% | -3.41% | -3.08% | -5.41% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -5.70 | -9.21 | -22.49 | -15.24 |
| Price-to-Sales (P/S) Ratio | 11985.90 | 69.69 | 675.55 | 334.60 |
| Price-to-Book (P/B) Ratio | 0.89 | -11.74 | -780.11 | -8.18 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.88 | -29.32 | -32.46 | -18.50 |
| Price-to-Operating Cash Flow Ratio | -4.18 | -30.06 | -33.81 | -20.44 |
| Price-to-Earnings Growth (PEG) Ratio | 0.10 | -0.06 | 0.84 | 0.00 |
| Enterprise Value Multiple | -4.40 | -8.97 | -30.93 | -19.10 |
| Enterprise Value | 417.67M | 1.11B | 1.18B | 1.23B |
| EV to EBITDA | -4.40 | -8.97 | -30.93 | -19.10 |
| EV to Sales | 10991.29 | 63.08 | 680.87 | 381.31 |
| EV to Free Cash Flow | -2.64 | -26.53 | -32.72 | -21.08 |
| EV to Operating Cash Flow | -3.83 | -27.21 | -34.08 | -23.29 |
| Tangible Book Value Per Share | 3.89 | -1.23 | -0.13 | -1.56 |
| Shareholders’ Equity Per Share | 3.97 | -1.12 | -0.02 | -1.45 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.19 | 0.02 | 0.04 |
| Net Income Per Share | -0.62 | -1.43 | -0.57 | -0.78 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.79 | 1.01 | 1.11 | 1.06 |
| Research & Development to Revenue | 1871.50 | 2.45 | 30.72 | 19.91 |
| SG&A to Revenue | 796.74 | 2.32 | 3.21 | 1.80 |
| Stock-Based Compensation to Revenue | 746.00 | 1.72 | 1.18 | 2.58 |
| Income Quality | 1.36 | 0.31 | 0.67 | 0.75 |
Currency in CNY
